Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems.

The Journal of antimicrobial chemotherapy - 1 Mar 2005

Livermore David M, Mushtaq Shazad, Warner Marina

Abstract excerpt

OBJECTIVES: Ertapenem and other carbapenems will be used increasingly, as extended-spectrum beta-lactamases become more prevalent even among community-acquired pathogens. There is, however, concern that this use will select for resistances to imipenem and meropenem in nosocomial pathogens, notably Pseudomonas aeruginosa, and we investigated the validity of this concern. METHODS: Single-step selection experiments...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Lactams
Share to Carbapenems
Share to Culture Media, Serum-Free

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Lactams

Share to Microbial Sensitivity Tests

Share to Porins

Share to Pseudomonas aeruginosa

Source

Identifiers

PMID: 15705643
DOI: 10.1093/jac/dki009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems.PMID 15705643Read ↗

Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems.Semantic proximity Read ↗

Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential.Semantic proximity Read ↗

Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa: the high potency of a new carbapenem doripenem.Semantic proximity Read ↗

Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.Semantic proximity Read ↗

Effect of beta-lactam antibiotics on the in vitro development of resistance in Pseudomonas aeruginosa.Semantic proximity Read ↗

Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.Semantic proximity Read ↗

Pharmacodynamic activity of ertapenem versus multidrug-resistant genotypically characterized extended-spectrum beta-lactamase-producing Escherichia coli using an in vitro model.Semantic proximity Read ↗

Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteriaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.